Ghaim said that most of the time, they’re looking for pain relief or to fix cold and flu symptoms. Crunchbase lists 1032 biotech companies and Angel List has 3024 with an average $5.1 million evaluation. Now Silicon Valley Technology can solve many things, but aging is the holy — and so far, unachievable — grail. “The innovation [in pain] hasn't been there and it’s unclear why that is,” said Alan Dunton, Senior VP, Research, Development and Regulatory Affairs at Purdue Pharma L.P, during a panel on pain treatment. For Jens Mikkelsen, Chief Scientific Officer at Bionomics Ltd., the problem is that pain is not easily quantifiable, “Pain is so many different things,” he said.

Source: Forbes January 23, 2017 19:58 UTC